SCHOTT Pharma AG & Co. KGaA

XTRA:1SXP Stock Report

Market Cap: €3.7b

SCHOTT Pharma KGaA Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1SXP?
Owner TypeNumber of SharesOwnership Percentage
General Public3,362,6672.23%
Institutions31,278,69520.8%
Private Companies115,973,25477%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 97.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
77%
Schott Glaswerke Beteiligungs- Und Export GmbH
115,973,254€2.8b0%no data
6.03%
Capital Research and Management Company
9,079,492€220.8m0%0.01%
4.92%
Qatar Holding LLC
7,407,407€180.1m0%0.42%
2.75%
T. Rowe Price Group, Inc.
4,138,569€100.7m-8.78%0.01%
1.31%
Deutsche Asset & Wealth Management
1,975,184€48.0m0%0.01%
1.24%
Union Asset Management Holding AG
1,873,503€45.6m0%0.03%
0.88%
The Vanguard Group, Inc.
1,328,007€32.3m0.26%no data
0.51%
Lazard Asset Management LLC
771,316€18.8m-7.41%0.02%
0.49%
Norges Bank Investment Management
743,543€18.1m0%no data
0.48%
Columbia Management Investment Advisers, LLC
716,697€17.4m0%no data
0.47%
BlackRock, Inc.
701,571€17.1m1.48%no data
0.39%
Deka Investment GmbH
587,033€14.3m-0.23%0.01%
0.24%
FundLogic SAS
368,185€9.0m0%0.53%
0.21%
Grandeur Peak Global Advisors, LLC
317,874€7.7m0%0.19%
0.16%
Schroder Investment Management Limited
242,615€5.9m0%no data
0.1%
Schroder Investment Management North America Inc.
149,926€3.6m28.1%0.01%
0.097%
Threadneedle Asset Management Ltd
146,730€3.6m0%0.14%
0.084%
Amundi Asset Management SAS
127,246€3.1m-47.7%no data
0.074%
Jupiter Fund Management Plc
111,600€2.7m0%0.01%
0.073%
Pictet Asset Management Limited
109,833€2.7m0%no data
0.069%
Dalton Capital (Guernsey) Limited
103,551€2.5m0%0.57%
0.068%
Eaton Vance Management
102,415€2.5m75.1%no data
0.06%
Baring Asset Management Limited
90,813€2.2m0%0.03%
0.056%
Montanaro Investment Managers Ltd.
85,000€2.1m0%0.11%
0.05%
HSBC Global Asset Management (UK) Limited
75,808€1.8m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SCHOTT Pharma AG & Co. KGaA is covered by 11 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gaurav JainBarclays
Victoria LambertBerenberg
Hugo SolvetBNP Paribas Exane